During the past decade, Centro Integral Medico SJR S.C. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integral Medico SJR S.C." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Integral Medico SJR S.C." are "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Asthma" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Centro Integral Medico SJR S.C." in a lesser frequency.

Most popular intervention types in "Centro Integral Medico SJR S.C." are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Lebrikizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Integral Medico SJR S.C." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centro Integral Medico SJR S.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Integral Medico SJR S.C., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Integral Medico SJR S.C., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".